Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 5Prostatic Neoplasms 3Melanoma 2Urinary Bladder Neoplasms 1Spondylitis, Ankylosing 1Skin Carcinoma 1Signs and Symptoms 1Rectal Neoplasms 1Psoriasis 1Pancreatic Neoplasms 1Overweight 1Ovarian Neoplasms 1Obesity-Related Malignant Neoplasm 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Malignant Solid Neoplasm 1Malignant Female Reproductive System Neoplasm 1Lymphedema 1Lupus Erythematosus, Systemic 1Kidney Neoplasms 1Inflammatory Bowel Diseases 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Endometrial Neoplasms 1Crohn Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Colitis, Ulcerative 1

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Arthritis, Reactive × Methods × 30 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡